What happened to the Blackmores (ASX:BKL) share price last earnings season?

Here we peel back the onion on what happened when Blackmores last reported earnings.

| More on:
blackmores share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Blackmores Limited (ASX: BKL) share price has climbed just over 2% in the last month. In comparison, the S&P/ASX 200 index (ASX: XJO) is up 1.5% over the same period.

In early trading today, the Blackmores share price is up 0.56% at $78.97 apiece.

As the nutritional supplement company prepares to report its FY21 earnings on Thursday, let's take a look at what happened to the Blackmores share price last earnings season back in February.

What did Blackmores deliver in its half year results?

Blackmores detailed a pattern of growth in its FY21 half-year results in February, including:

  • Revenue of $302.6 million that grew 4% on a constant currency basis
  • International and China revenue growth of 13% and 25% respectively
  • 10% decline in ANZ revenue to $148 million
  • Net profit after tax (NPAT) of $19.4 million, an 8% increase from the year prior
  • Fully franked interim dividend of 29 cents per share.

While Blackmores did not shed any colour on guidance expectations, it did state that revenue in H2 would be "slightly lower" than H1.

Furthermore, it announced it would hand back $2.4 million of the $10.4 million in Jobkeeper assistance provided by the government for COVID-19 relief.

How did the Blackmores share price react?

The results were well received by the market, as investors drove the Blackmores share price north in the days following the announcement.

Blackmores shares climbed around 10% in the two days after the report, peaking at $81.41 before retracing to $76.57 the week after.

Afterwards, the Blackmores share price regained momentum and again shot back up near its 52-week high, closing at $87.19 on 15 March.

One month after its FY21 half-year results, Blackmores shares closed at $82.92, a 12% climb, despite no other market-sensitive information during this time.

Considering how its earnings growth was a positive to the Blackmores share price in February, investors will no doubt hope for a similar performance this time around.

This is especially true when factoring the recent run-up on the charts the company's shares have exhibited since May.

At the current Blackmores share price, the company has a market capitalisation of $1.5 billion.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Blackmores Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Healthcare Shares

This ASX All Ords share is diving 18% as inflation pain draws blood

This healthcare company delivered a trading update at its annual general meeting today.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Up 427% this year, why today is a big day for Mesoblast shares

Why is everyone talking about Mesoblast shares on Friday?

Read more »